Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors
Regan M. Memmott, Adam R. Wolfe, David P. Carbone, Terence M. Williams
Topics & Concepts
MedicineLung cancerImmune systemOncologyNivolumabImmunotherapyClinical trialImmune checkpointCancerInternal medicineImmunologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations